Why BluGlass (ASX:BLG) Has Refinanced With an A$8 Million Facility Secured Against R&D Tax Refunds

Sonal Goyal

23 October 2026 05:42 PM AEDT

Why BluGlass (ASX:BLG) Has Refinanced With an A$8 Million Facility Secured Against R&D Tax Refunds

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

BluGlass reported closing cash of A$8.655 million for the September 2026 quarter.
An A$8.0 million Facility from Rockford, secured against R&D tax incentive refunds, was fully drawn on 25 September 2026 and replaced the A$2.27 million Radium facility.
Receipts from customers were A$1.662 million, and the Appendix 4C estimates 2.8 quarters of funding.

BluGlass Limited (ASX:BLG) has reported closing cash of A$8.655 million for the September 2026 quarter, after refinancing its Debt through an A$8.0 million facility from Rockford secured against Research and Development tax incentive refunds. Its quarterly update also covers customer contracts for its gallium nitride laser technology.

The facility was fully drawn on 25 September 2026 and replaced the A$2.27 million Radium facility, giving a net Liquidity gain of about A$5.4 million. Interest is 16.5 per cent a year, capitalised daily, and the 2.5 per cent establishment fee is split between A$100,000 capitalised and A$100,000 payable in shares. The balance at quarter-end was A$8.1 million. Security is first-ranking over the FY26 and FY27 R&D tax incentive refunds, with limited security over other assets.

A A$6.1 million FY26 refund was received in October 2026, and A$2.75 million was applied to the loan. The remainder must be repaid from the FY27 refund, no later than 1 March 2028.

Customers and development work

Receipts from customers were A$1.662 million. The company received a Phase II contract from US photonics company Uviquity worth A$1.4 million (US$1.0 million) in July 2026. On 21 September 2026 it announced an early-stage project of about A$286,000 (US$200,000) with an unnamed global photonics company, involving a feasibility study of 3 to 5 months. BluGlass (ASX:BLG) also reports continuing work with an unnamed US defence prime and an unnamed data-storage company, with no values disclosed, and completion of Year Three of the US Microelectronics Commons programme. No product sales Revenue is itemised, and the company describes its model as paid development aimed at future product supply.

Cash flow

Net operating cash outflow was A$3.123 million, including research and development of A$1.622 million and staff costs of A$2.233 million. Investing outflow was A$2.421 million, including A$2.15 million of payments for businesses that the report does not explain. Financing brought in A$2.922 million, from A$8.0 million of borrowings less A$4.54 million of repayments and transaction costs. Cash fell from A$11.343 million at 30 June. The Appendix 4C estimates 2.8 quarters of funding, with no unused facilities.

The company describes its approach as project-to-product: customers fund development work that is intended to lead to future Supply of lasers and related products. Its stated priorities are Manufacturing repeatability and progressing visible gallium nitride laser products for defence, quantum, scientific, medical and photonics uses. The Uviquity Phase II work covers engineering, packaging, laser integration and laser purchases under a joint development agreement.

The quarter's other items include presentations by the chief executive, the executive chair and a senior vice president at the iAccess Alpha conference on 15 and 16 September 2026. Related-party payments of A$114,000 were fees to the executive chair and a non-executive director. The 4C does not give a separate revenue figure for the quarter. The company reports that foreign exchange movements reduced cash by A$66,000 in the quarter, and the report does not explain the A$2.15 million payments line.

Governance and next steps

Jim Haden became managing director on 13 July 2026, and Yam Rubenstein was appointed a non-executive director on 21 August 2026. The company will hold its annual general meeting, with a Shareholder question and answer session, on 23 October 2026 in Sydney.

Risks

Features of the arrangements disclosed include the facility's Interest Rate of 16.5 per cent a year, capitalised daily, and the fees. Repayment depends on R&D refunds, the Uviquity and feasibility work are early stage and outcomes are not guaranteed, and some contracts are in US dollars.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.